Implementation of ACT Through Facebook for Teenagers With Asthma
NCT ID: NCT01675921
Last Updated: 2020-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2012-09-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Use of the Asthma Control Test (ACT) to Improve Care of Children With Asthma
NCT03036982
To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma
NCT02662413
School-based Asthma Care for Teens (SB-ACT)
NCT02206061
Multisystemic Therapy to Reduce Health Disparities in Adolescents With Asthma
NCT00916240
Self-management Intervention to Improve Adolescents' Asthma Control
NCT03536416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The goal is to improve health outcomes in patients with asthma by measuring adherence to the use of monitoring tool, follow-up visits to their specialist, and hospitalization/Emergency Department (ED) visits. To achieve this, the investigators will use a novel technology platform that is simple, secure, private and easily scalable to other relevant sites and groups, without the need for additional investment. Currently, patients take the ACT survey only during their scheduled office appointments. The aim of the study is to increase the use of ACT to monitor patients who see a pediatric pulmonologist to promote regular self-monitoring.
ACT is a short symptom-based survey consisting of 5 questions, validated in English and Spanish. Participants will receive reminders on Facebook every month to login to the study website to complete the ACT survey therefore allowing patients to easily take the survey on a regular basis, and receive reminders and educational content in the media spaces they already inhabit. Participants would receive reminders and links in the same way they would receive other reminders or notifications from Facebook. The system will rate asthma control and send patients and their specialist notification of status if it reaches critical levels, defined as a score of 14 or lower on the ACT survey. This will be a system generated notification, based on a protocol developed in conjunction with the physicians at the Massachusetts General Hospital (MGH) pediatric pulmonary department.
The intervention will study the efficacy of electronic social networks in engaging teenagers in their asthma control over time, using a simple but effective symptom-based survey tool. Both patients and providers would receive notifications in case of deteriorating control, which could result in early intervention and lead to better clinical outcomes by prompting timely intervention by the clinician. The Center for Connected Health (CCH) will work with the MGH Department of Pulmonology, as well as the Pediatric Asthma group at Partners Community HealthCare Inc. (PCHI) to enroll ambulatory teenagers with asthma in the research study for one year.
120 participants will be enrolled and randomly assigned to one of two groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants will continue to receive medical care from their doctor as usual.
Participants will have access to this study website at the start and at the end of the study.
No interventions assigned to this group
Facebook group
Participants will continue to receive medical care from their doctor as usual.
Participants will have access to the study website at all times throughout the study.
Participants will have access to the secret study group on Facebook for 12 months.
Participants will take the ACT survey once a month for 12 months.
Facebook group
Facebook will be used to remind participants to take the ACT survey once every month for 12 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Facebook group
Facebook will be used to remind participants to take the ACT survey once every month for 12 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of asthma by a PCP or a specialist at a Partners affiliated hospital/health center.
* Access to computer with internet.
* Active email account
* Fluency in English (spoken and written)
* Be on controller medications (such as: inhaled corticosteroids, cromolyn sodium and nedocromil sodium, long-acting beta-agonists (LABAs), and methylxanthines) to control asthma and prevent symptoms from developing.
* Have an active account on Facebook
Exclusion Criteria
* Cognitive impairment.
14 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph C. Kvedar
Dermatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kamal Jethwani, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Partners Healthcare, Center for Connected Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Partners Center for Connected Health
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-P-000674/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.